Works matching IS 13889842 AND DT 2023 AND VI 25 AND IP 4
Results: 26
April 2023 at a glance: focus on diagnosis and comorbidities.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 445, doi. 10.1002/ejhf.2866
- By:
- Publication type:
- Article
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 469, doi. 10.1002/ejhf.2830
- By:
- Publication type:
- Article
Splanchnic nerve block with botulinum toxin for therapy of chronic heart failure – mechanism of action (SPONGE‐HF).
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 594, doi. 10.1002/ejhf.2829
- By:
- Publication type:
- Article
Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 478, doi. 10.1002/ejhf.2828
- By:
- Publication type:
- Article
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 497, doi. 10.1002/ejhf.2827
- By:
- Publication type:
- Article
For the best management, please ask for assistance!
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 573, doi. 10.1002/ejhf.2826
- By:
- Publication type:
- Article
Efficacy of sodium–glucose cotransporter 2 inhibitors and angiotensin receptor–neprilysin inhibitors for heart failure in black patients: a systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 591, doi. 10.1002/ejhf.2825
- By:
- Publication type:
- Article
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 510, doi. 10.1002/ejhf.2824
- By:
- Publication type:
- Article
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX‐AHF‐2 trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 541, doi. 10.1002/ejhf.2820
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 488, doi. 10.1002/ejhf.2818
- By:
- Publication type:
- Article
Sex differences in heart failure: the evolving use of biomarkers.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 448, doi. 10.1002/ejhf.2817
- By:
- Publication type:
- Article
Dosing of iron supplementation for iron‐deficient patients with heart failure: should we prefer more intensive or less intensive repletion targets?
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 454, doi. 10.1002/ejhf.2816
- By:
- Publication type:
- Article
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 457, doi. 10.1002/ejhf.2814
- By:
- Publication type:
- Article
Time to reconsider the perception and management of hypertensive heart disease.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 450, doi. 10.1002/ejhf.2811
- By:
- Publication type:
- Article
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 528, doi. 10.1002/ejhf.2810
- By:
- Publication type:
- Article
Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 553, doi. 10.1002/ejhf.2809
- By:
- Publication type:
- Article
Variant and wild type transthyretin amyloidosis: two sides of the same coin or different currencies in different pockets?
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 525, doi. 10.1002/ejhf.2808
- By:
- Publication type:
- Article
Cell therapy for heart failure: lessons learned from SCIENCE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 588, doi. 10.1002/ejhf.2807
- By:
- Publication type:
- Article
Reply to 'Interleukin‐6 in acute heart failure: it does work, but how much?'.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 597, doi. 10.1002/ejhf.2802
- By:
- Publication type:
- Article
Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 562, doi. 10.1002/ejhf.2796
- By:
- Publication type:
- Article
Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 538, doi. 10.1002/ejhf.2787
- By:
- Publication type:
- Article
Interleukin‐6 in acute heart failure: it does work, but how much? Letter regarding the article 'Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure'.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 597, doi. 10.1002/ejhf.2785
- By:
- Publication type:
- Article
Letter regarding the article 'Little at a time: trying to understand the battery of benefits of sodium–glucose cotransporter 2 inhibitors in heart failure'.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 598, doi. 10.1002/ejhf.2782
- By:
- Publication type:
- Article
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 515, doi. 10.1002/ejhf.2776
- By:
- Publication type:
- Article
Effect of allogeneic adipose tissue‐derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction – the SCIENCE trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 576, doi. 10.1002/ejhf.2772
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. i, doi. 10.1002/ejhf.2791
- Publication type:
- Article